Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bio-Key International Inc. (NASDAQ: BKYI) closed the day trading at $0.71 down -18.30% from the previous closing price of $0.87. In other words, the price has decreased by -$18.30 from its previous closing price. On the day, 0.6 million shares were traded. BKYI stock price reached its highest trading level at $0.8429 during the session, while it also had its lowest trading level at $0.651.
Ratios:
For a better understanding of BKYI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.46 and its Current Ratio is at 0.54.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 01 ’23 when DEPASQUALE MICHAEL W bought 20,000 shares for $0.18 per share. The transaction valued at 3,600 led to the insider holds 306,827 shares of the business.
Sullivan James David bought 20,000 shares of BKYI for $3,300 on Nov 30 ’23. The Chief Legal Officer now owns 388,171 shares after completing the transaction at $0.17 per share. On Nov 24 ’23, another insider, Sullivan James David, who serves as the Chief Legal Officer of the company, bought 29,668 shares for $0.16 each. As a result, the insider paid 4,862 and bolstered with 358,168 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BKYI now has a Market Capitalization of 2139059 and an Enterprise Value of 2416930. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.23. Its current Enterprise Value per Revenue stands at 0.347 whereas that against EBITDA is -0.377.
Stock Price History:
The Beta on a monthly basis for BKYI is 0.31, which has changed by -0.92265797 over the last 52 weeks, in comparison to a change of 0.32295227 over the same period for the S&P500. Over the past 52 weeks, BKYI has reached a high of $10.31, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is -46.67%, while the 200-Day Moving Average is calculated to be -60.16%.
Shares Statistics:
Over the past 3-months, BKYI traded about 2.92M shares per day on average, while over the past 10 days, BKYI traded about 345730 shares per day. A total of 1.98M shares are outstanding, with a floating share count of 1.78M. Insiders hold about 9.95% of the company’s shares, while institutions hold 7.18% stake in the company. Shares short for BKYI as of 1726185600 were 279588 with a Short Ratio of 0.10, compared to 1723680000 on 9765. Therefore, it implies a Short% of Shares Outstanding of 279588 and a Short% of Float of 9.54.
Earnings Estimates
At present, 1.0 analysts are actively evaluating the performance of Bio-Key International Inc. (BKYI) in the stock market.The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.46 and low estimates of -$0.46.
Analysts are recommending an EPS of between -$2.23 and -$2.23 for the fiscal current year, implying an average EPS of -$2.23. EPS for the following year is -$1.47, with 1.0 analysts recommending between -$1.47 and -$1.47.
Revenue Estimates
1 analysts predict $1.6M in revenue for the current quarter. It ranges from a high estimate of $1.6M to a low estimate of $1.6M. As of the current estimate, Bio-Key International Inc.’s year-ago sales were $1.83MFor the next quarter, 1 analysts are estimating revenue of $1.9M. There is a high estimate of $1.9M for the next quarter, whereas the lowest estimate is $1.9M.
Based on 1 analysts’ estimates, the company’s revenue will be $8.5M in the next fiscal year. The high estimate is $8.5M and the low estimate is $8.5M.
